Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nikolaos Nomikos
Observed names:
N Nomikos,
N. Nomikos,
Nikos Nomikos
Institution:
University of West Attica
Observed institution:
University of West Attica
ORCID:
0000-0001-7871-4132
Observed ORCID:
0000-0001-7871-4132
OpenAlex ID:
A5045757146
Cost–Benefit Analysis of Single versus Repeated Use of Single-Use Devices in Cataract Surgery
2021
·
Panagiota Naoum
, Sotiria Palioura
, et al.
·
Clinical ophthalmology
·
8
PDF
A 10-year economic analysis of HIV management in Greece: evidence of efficient resource allocation
2021
·
Kostas Athanasakis
, Vasiliki Naoum
, et al.
·
Current Medical Research and Opinion
·
4
Cost-effectiveness Analysis and Impact on Length of Hospital Stay of the Introduction of Remdesivir as a Treatment Option for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen in Greece Versus Standard of Care
2023
·
Kostas Athanasakis
, Konstantinos Zisis
, et al.
·
Clinical Therapeutics
·
3
A Cost-Effectiveness and Budget Impact Analysis of AbobotulinumtoxinA in Greece
2023
·
Nikolaos Nomikos
, Christos Eleftheriou
, et al.
·
Toxins
·
3
PDF
Hospital pharmaceutical expenditure: a need to focus on an ‘obscure’ and growing component of pharmaceutical spending
2022
·
Kostas Athanasakis
, Nikos Nomikos
, et al.
·
European Journal of Hospital Pharmacy
·
3
PDF
EE478 A Budget Impact Analysis of Introducing Filgotinib as a First-Line Treatment for Moderate to Severe Ulcerative Colitis in Greece
2024
·
N Nomikos
, P Naoum
, et al.
·
Value in Health
·
1
PDF
EPH77 Prevalence of Common Chronic Diseases Among Overweight and Obese Adults in Greece
2022
·
N Nomikos
, G Agorastos
, et al.
·
Value in Health
·
1
EE477 A Budget Impact Analysis of Introducing Filgotinib for the Treatment of Rheumatoid Arthritis in Greece
2024
·
N Nomikos
, P Naoum
, et al.
·
Value in Health
EE135 Cost-Effectiveness Analysis of Filgotinib as a First-Line Treatment for Biologic-Naive Patients With Ulcerative Colitis in Greece
2024
·
N Nomikos
, P Naoum
, et al.
·
Value in Health
PDF
EE134 Cost-Effectiveness Analysis of Filgotinib Versus Tofacitinib As First-Line Treatments for Rheumatoid Arthritis in Greece
2024
·
N Nomikos
, P Naoum
, et al.
·
Value in Health
PDF
HPR239 Alternative Ways of Financing Healthcare Systems: Investigating the Fiscal Impact of Health Taxes in Greece
2024
·
P Panagiotopoulos
, P Naoum
, et al.
·
Value in Health
PDF
HPR240 A Rapid Review of Key Challenges and Success Factors in Implementing Managed Entry Agreements for Pharmaceuticals: Lessons for Greece
2024
·
K Zisis
, E Karampli
, et al.
·
Value in Health
PDF
EE689 A Cost-Effectiveness Analysis of Atezolizumab as Adjuvant Treatment (Monotherapy) for Adult Patients With Non-Small Cell Lung Cancer Following Resection and Platinum-Based Chemotherapy in Greece
2023
·
N. Nomikos
, P. Naoum
, et al.
·
Value in Health
PDF
EE232 Cost-Effectiveness of a Genomic Profiling Test for HRD Determination in Ovarian Cancer Into the Current Clinical Practice for Platinum-Sensitive Patients With Advanced Ovarian Cancer in Greece
2023
·
K. Zisis
, N. Nomikos
, et al.
·
Value in Health
PDF
EE666 Cost-Analysis of the Introduction of a Second Generation Biomarker Breast Cancer Prognostic Test for the Management of Early Breast Cancer in Greece
2022
·
K Zisis
, N Nomikos
, et al.
·
Value in Health
EE256 Budget Impact Analysis of the Introduction of a Novel Gene Expression Biomarker Test for Early-Stage Breast Cancer Patients in Cyprus
2022
·
K Zisis
, N Nomikos
, et al.
·
Value in Health
PDF
EE251 A Budget Impact Analysis of the Introduction of Generics Ambrisentan and Tadalafil for the Treatment of Pulmonary Arterial Hypertension in Greece
2022
·
N Nomikos
, I Kyriopoulos
, et al.
·
Value in Health
EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece
2022
·
K Athanasakis
, N Nomikos
, et al.
·
Value in Health
PDF
EE255 Budget Impact Analysis of the Introduction of a Prognostic Prostate Genomic Biomarker Cancer Test in the Management of Localized Prostate Cancer Patients for Greece
2022
·
K Zisis
, N Nomikos
, et al.
·
Value in Health
HSD36 Generic Penetration in the Market for Antidiabetics, Lipid Modifying Agents and Psychoeleptics/Psychoanaleptics: A Comparative Analysis of Data From 18 European Markets
2022
·
A Giannakopoulou
, N Nomikos
, et al.
·
Value in Health
HPR118 An Updated Estimate of the Direct Cost of the COVID-19 Pandemic for the Greek Healthcare System
2022
·
K Athanasakis
, N Nomikos
, et al.
·
Value in Health
PDF
Individuals' personal characteristics associated with private health insurance policy possession in Greece
2021
·
Nikos Nomikos
, Panagiota Naoum
, et al.
·
The International Journal of Health Planning and Management
PNS99 Personal Characteristics Associated with Subscription to Private Health Insurance in Greece − Results from the ″Health & Welfare″ Survey
2020
·
N. Nomikos
, P. Naoum
, et al.
·
Value in Health
Show more works
View as search
Works count:
23
Citation count:
23
H-index:
3
I10-index:
Year
Topic
Type